 | • レポートコード：GIR-105X08073 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、婦人科がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。婦人科がん治療薬の種類別市場規模（アルキル化剤、植物アルカロイド、アントラサイクリン、抗生物質、その他）、用途別市場規模（病院薬局、小売薬局、Eコマース）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・婦人科がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Holdings、AstraZeneca、Sanofi、Eli Lilly、Pfizer、Takeda Pharmaceuticals、Bristol-Myers Squibb、Merck、Dr Reddy’s Laboratories、Johnson & Johnson、GlaxoSmithKline、Apotex、Hoffmann-La Roche、Novartis、Teva Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アルキル化剤、植物アルカロイド、アントラサイクリン、抗生物質、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、Eコマース ・婦人科がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・婦人科がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・婦人科がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・婦人科がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・婦人科がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gynaecological Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gynaecological Cancer Drugs size is estimated to be xx million in 2021 from USD 6536.7 million in 2020, with a change of XX% between 2020 and 2021. The global Gynaecological Cancer Drugs market size is expected to grow at a CAGR of 3.2% for the next five years.
Market segmentation
Gynaecological Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Alkylating Agent
Plant Alkaloid
Anthracyclines
Antitumor Antibiotic
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
E-commerce
The key market players for global Gynaecological Cancer Drugs market are listed below:
Roche Holdings
AstraZeneca
Sanofi
Eli Lilly
Pfizer
Takeda Pharmaceuticals
Bristol-Myers Squibb
Merck
Dr Reddy’s Laboratories
Johnson & Johnson
GlaxoSmithKline
Apotex
Hoffmann-La Roche
Novartis
Teva Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Gynaecological Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gynaecological Cancer Drugs, with price, sales, revenue and global market share of Gynaecological Cancer Drugs from 2019 to 2021.
Chapter 3, the Gynaecological Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gynaecological Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Gynaecological Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Gynaecological Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gynaecological Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gynaecological Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Alkylating Agent
1.2.3 Plant Alkaloid
1.2.4 Anthracyclines
1.2.5 Antitumor Antibiotic
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gynaecological Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Global Gynaecological Cancer Drugs Market Size & Forecast
1.4.1 Global Gynaecological Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Gynaecological Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Gynaecological Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
1.5 Global Gynaecological Cancer Drugs Production Capacity Analysis
1.5.1 Global Gynaecological Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Gynaecological Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gynaecological Cancer Drugs Market Drivers
1.6.2 Gynaecological Cancer Drugs Market Restraints
1.6.3 Gynaecological Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche Holdings
2.1.1 Roche Holdings Details
2.1.2 Roche Holdings Major Business
2.1.3 Roche Holdings Gynaecological Cancer Drugs Product and Services
2.1.4 Roche Holdings Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Gynaecological Cancer Drugs Product and Services
2.2.4 AstraZeneca Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Gynaecological Cancer Drugs Product and Services
2.3.4 Sanofi Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Gynaecological Cancer Drugs Product and Services
2.4.4 Eli Lilly Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Gynaecological Cancer Drugs Product and Services
2.5.4 Pfizer Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Takeda Pharmaceuticals
2.6.1 Takeda Pharmaceuticals Details
2.6.2 Takeda Pharmaceuticals Major Business
2.6.3 Takeda Pharmaceuticals Gynaecological Cancer Drugs Product and Services
2.6.4 Takeda Pharmaceuticals Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Gynaecological Cancer Drugs Product and Services
2.7.4 Bristol-Myers Squibb Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Gynaecological Cancer Drugs Product and Services
2.8.4 Merck Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Dr Reddy’s Laboratories
2.9.1 Dr Reddy’s Laboratories Details
2.9.2 Dr Reddy’s Laboratories Major Business
2.9.3 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Product and Services
2.9.4 Dr Reddy’s Laboratories Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Gynaecological Cancer Drugs Product and Services
2.10.4 Johnson & Johnson Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Gynaecological Cancer Drugs Product and Services
2.11.4 GlaxoSmithKline Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Apotex
2.12.1 Apotex Details
2.12.2 Apotex Major Business
2.12.3 Apotex Gynaecological Cancer Drugs Product and Services
2.12.4 Apotex Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Hoffmann-La Roche
2.13.1 Hoffmann-La Roche Details
2.13.2 Hoffmann-La Roche Major Business
2.13.3 Hoffmann-La Roche Gynaecological Cancer Drugs Product and Services
2.13.4 Hoffmann-La Roche Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Gynaecological Cancer Drugs Product and Services
2.14.4 Novartis Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Teva Pharmaceutical
2.15.1 Teva Pharmaceutical Details
2.15.2 Teva Pharmaceutical Major Business
2.15.3 Teva Pharmaceutical Gynaecological Cancer Drugs Product and Services
2.15.4 Teva Pharmaceutical Gynaecological Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Gynaecological Cancer Drugs Sales by Manufacturer
3.1 Global Gynaecological Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gynaecological Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gynaecological Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gynaecological Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Gynaecological Cancer Drugs Manufacturer Market Share
3.5 Global Gynaecological Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gynaecological Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gynaecological Cancer Drugs Market Size by Region
4.1.1 Global Gynaecological Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Gynaecological Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Gynaecological Cancer Drugs Revenue (2016-2026)
4.3 Europe Gynaecological Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Gynaecological Cancer Drugs Revenue (2016-2026)
4.5 South America Gynaecological Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Gynaecological Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gynaecological Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Gynaecological Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Gynaecological Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gynaecological Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Gynaecological Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Gynaecological Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gynaecological Cancer Drugs Sales by Type (2016-2026)
7.2 North America Gynaecological Cancer Drugs Sales by Application (2016-2026)
7.3 North America Gynaecological Cancer Drugs Market Size by Country
7.3.1 North America Gynaecological Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Gynaecological Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gynaecological Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Gynaecological Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Gynaecological Cancer Drugs Market Size by Country
8.3.1 Europe Gynaecological Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Gynaecological Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gynaecological Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Gynaecological Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Gynaecological Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Gynaecological Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gynaecological Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gynaecological Cancer Drugs Sales by Type (2016-2026)
10.2 South America Gynaecological Cancer Drugs Sales by Application (2016-2026)
10.3 South America Gynaecological Cancer Drugs Market Size by Country
10.3.1 South America Gynaecological Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Gynaecological Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gynaecological Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Gynaecological Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Gynaecological Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Gynaecological Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gynaecological Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gynaecological Cancer Drugs Typical Distributors
12.3 Gynaecological Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gynaecological Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gynaecological Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Holdings Basic Information, Manufacturing Base and Competitors
Table 4. Roche Holdings Major Business
Table 5. Roche Holdings Gynaecological Cancer Drugs Product and Services
Table 6. Roche Holdings Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Gynaecological Cancer Drugs Product and Services
Table 10. AstraZeneca Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Gynaecological Cancer Drugs Product and Services
Table 14. Sanofi Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Gynaecological Cancer Drugs Product and Services
Table 18. Eli Lilly Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Gynaecological Cancer Drugs Product and Services
Table 22. Pfizer Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Pharmaceuticals Major Business
Table 25. Takeda Pharmaceuticals Gynaecological Cancer Drugs Product and Services
Table 26. Takeda Pharmaceuticals Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 28. Bristol-Myers Squibb Major Business
Table 29. Bristol-Myers Squibb Gynaecological Cancer Drugs Product and Services
Table 30. Bristol-Myers Squibb Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Gynaecological Cancer Drugs Product and Services
Table 34. Merck Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr Reddy’s Laboratories Major Business
Table 37. Dr Reddy’s Laboratories Gynaecological Cancer Drugs Product and Services
Table 38. Dr Reddy’s Laboratories Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson & Johnson Major Business
Table 41. Johnson & Johnson Gynaecological Cancer Drugs Product and Services
Table 42. Johnson & Johnson Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Gynaecological Cancer Drugs Product and Services
Table 46. GlaxoSmithKline Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Apotex Basic Information, Manufacturing Base and Competitors
Table 48. Apotex Major Business
Table 49. Apotex Gynaecological Cancer Drugs Product and Services
Table 50. Apotex Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 52. Hoffmann-La Roche Major Business
Table 53. Hoffmann-La Roche Gynaecological Cancer Drugs Product and Services
Table 54. Hoffmann-La Roche Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Gynaecological Cancer Drugs Product and Services
Table 58. Novartis Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceutical Major Business
Table 61. Teva Pharmaceutical Gynaecological Cancer Drugs Product and Services
Table 62. Teva Pharmaceutical Gynaecological Cancer Drugs Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Gynaecological Cancer Drugs Sales by Manufacturer (2019-2021e) & (Kg)
Table 64. Global Gynaecological Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Gynaecological Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Gynaecological Cancer Drugs Production Capacity by Company, (Kg): 2020 VS 2021
Table 67. Head Office and Gynaecological Cancer Drugs Production Site of Key Manufacturer
Table 68. Gynaecological Cancer Drugs New Entrant and Capacity Expansion Plans
Table 69. Gynaecological Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 70. Global Gynaecological Cancer Drugs Sales by Region (2016-2021e) & (Kg)
Table 71. Global Gynaecological Cancer Drugs Sales by Region (2021-2026) & (Kg)
Table 72. Global Gynaecological Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Gynaecological Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 75. Global Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 76. Global Gynaecological Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Gynaecological Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Gynaecological Cancer Drugs Price by Type (2016-2021e) & (USD/Kg)
Table 79. Global Gynaecological Cancer Drugs Price by Type (2021-2026) & (USD/Kg)
Table 80. Global Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 81. Global Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 82. Global Gynaecological Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Gynaecological Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Gynaecological Cancer Drugs Price by Application (2016-2021e) & (USD/Kg)
Table 85. Global Gynaecological Cancer Drugs Price by Application (2021-2026) & (USD/Kg)
Table 86. North America Gynaecological Cancer Drugs Sales by Country (2016-2021e) & (Kg)
Table 87. North America Gynaecological Cancer Drugs Sales by Country (2021-2026) & (Kg)
Table 88. North America Gynaecological Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Gynaecological Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 91. North America Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 92. North America Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 93. North America Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 94. Europe Gynaecological Cancer Drugs Sales by Country (2016-2021e) & (Kg)
Table 95. Europe Gynaecological Cancer Drugs Sales by Country (2021-2026) & (Kg)
Table 96. Europe Gynaecological Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Gynaecological Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 99. Europe Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 100. Europe Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 101. Europe Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 102. Asia-Pacific Gynaecological Cancer Drugs Sales by Region (2016-2021e) & (Kg)
Table 103. Asia-Pacific Gynaecological Cancer Drugs Sales by Region (2021-2026) & (Kg)
Table 104. Asia-Pacific Gynaecological Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Gynaecological Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 107. Asia-Pacific Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 108. Asia-Pacific Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 109. Asia-Pacific Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 110. South America Gynaecological Cancer Drugs Sales by Country (2016-2021e) & (Kg)
Table 111. South America Gynaecological Cancer Drugs Sales by Country (2021-2026) & (Kg)
Table 112. South America Gynaecological Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Gynaecological Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 115. South America Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 116. South America Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 117. South America Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 118. Middle East & Africa Gynaecological Cancer Drugs Sales by Country (2016-2021e) & (Kg)
Table 119. Middle East & Africa Gynaecological Cancer Drugs Sales by Country (2021-2026) & (Kg)
Table 120. Middle East & Africa Gynaecological Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Gynaecological Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Gynaecological Cancer Drugs Sales by Type (2016-2021e) & (Kg)
Table 123. Middle East & Africa Gynaecological Cancer Drugs Sales by Type (2021-2026) & (Kg)
Table 124. Middle East & Africa Gynaecological Cancer Drugs Sales by Application (2016-2021e) & (Kg)
Table 125. Middle East & Africa Gynaecological Cancer Drugs Sales by Application (2021-2026) & (Kg)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Gynaecological Cancer Drugs Typical Distributors
Table 129. Gynaecological Cancer Drugs Typical Customers
List of Figures
Figure 1. Gynaecological Cancer Drugs Picture
Figure 2. Global Gynaecological Cancer Drugs Sales Market Share by Type in 2020
Figure 3. Alkylating Agent
Figure 4. Plant Alkaloid
Figure 5. Anthracyclines
Figure 6. Antitumor Antibiotic
Figure 7. Others
Figure 8. Global Gynaecological Cancer Drugs Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. E-commerce
Figure 12. Global Gynaecological Cancer Drugs Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 13. Global Gynaecological Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Gynaecological Cancer Drugs Sales (2016-2026) & (Kg)
Figure 15. Global Gynaecological Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 16. Global Gynaecological Cancer Drugs Production Capacity (2016-2026) & (Kg)
Figure 17. Global Gynaecological Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Gynaecological Cancer Drugs Market Drivers
Figure 19. Gynaecological Cancer Drugs Market Restraints
Figure 20. Gynaecological Cancer Drugs Market Trends
Figure 21. Global Gynaecological Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 22. Global Gynaecological Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 23. Gynaecological Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Gynaecological Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Gynaecological Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Gynaecological Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 27. Global Gynaecological Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 28. North America Gynaecological Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Europe Gynaecological Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Gynaecological Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 31. South America Gynaecological Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Gynaecological Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Global Gynaecological Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 34. Global Gynaecological Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 35. Global Gynaecological Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 36. Global Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 37. Global Gynaecological Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 38. Global Gynaecological Cancer Drugs Price by Application (2016-2026) & (USD/Kg)
Figure 39. North America Gynaecological Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America Gynaecological Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 42. North America Gynaecological Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Gynaecological Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe Gynaecological Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 49. Europe Gynaecological Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Gynaecological Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Gynaecological Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Gynaecological Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Gynaecological Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Gynaecological Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Gynaecological Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Gynaecological Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Gynaecological Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Gynaecological Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Gynaecological Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Gynaecological Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
卵巣がん薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment…- 世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の腫瘍/がん治療薬市場 2021：企業別、地域別、種類・用途別 The Oncology/Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 肝臓癌治療薬の世界市場2018-2025 Liver cancer resists most chemo drugs. The liver cancer drugs that have been most effective as systemic chemo in liver cancer are doxorubicin (Adriamycin), 5-fluorouracil, and cisplatin. But even these drugs shrink only a small portion of tumors, and the responses often do not last long.In 2018, the…
- 肝臓癌治療薬の世界市場2018-2025 Liver cancer resists most chemo drugs. The liver cancer drugs that have been most effective as systemic chemo in liver cancer are doxorubicin (Adriamycin), 5-fluorouracil, and cisplatin. But even these drugs shrink only a small portion of tumors, and the responses often do not last long.In 2018, the…